These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2689091)

  • 21. [Molecular mechanism of action of sulfonylureas].
    Ammon HP
    Dtsch Med Wochenschr; 1988 May; 113(21):864-70. PubMed ID: 3286184
    [No Abstract]   [Full Text] [Related]  

  • 22. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs.
    Beyer J; Haupt E; Cordes U; Kutschera J; Schöffling K
    Horm Metab Res; 1973 Jan; 5(1):9-13. PubMed ID: 4196346
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiovascular effects of sulphonylureas: role of K(ATP) channels.
    Howes LG
    Diabetes Obes Metab; 2000 Apr; 2(2):67-73. PubMed ID: 11220526
    [No Abstract]   [Full Text] [Related]  

  • 24. Antidiabetic sulfonylurea stimulates insulin secretion independently of plasma membrane KATP channels.
    Geng X; Li L; Bottino R; Balamurugan AN; Bertera S; Densmore E; Su A; Chang Y; Trucco M; Drain P
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E293-301. PubMed ID: 17405830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of glipizide on insulin secretion from cultured human fetal pancreatic islets.
    Peterson CM; Miller N; Walker L; Formby B
    Diabetes Care; 1986; 9(5):556-7. PubMed ID: 2429808
    [No Abstract]   [Full Text] [Related]  

  • 26. Pancreatic action of the sulfonylureas.
    Grodsky GM; Epstein GH; Fanska R; Karam JH
    Fed Proc; 1977 Dec; 36(13):2714-9. PubMed ID: 200493
    [No Abstract]   [Full Text] [Related]  

  • 27. [The sulfonylurea receptor].
    Inagaki N; Gonoi T; Seino S
    Seikagaku; 1997 Sep; 69(9):1067-80. PubMed ID: 9364874
    [No Abstract]   [Full Text] [Related]  

  • 28. A red-shifted photochromic sulfonylurea for the remote control of pancreatic beta cell function.
    Broichhagen J; Frank JA; Johnston NR; Mitchell RK; Šmid K; Marchetti P; Bugliani M; Rutter GA; Trauner D; Hodson DJ
    Chem Commun (Camb); 2015 Apr; 51(27):6018-21. PubMed ID: 25744824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PKC-dependent stimulation of exocytosis by sulfonylureas in pancreatic beta cells.
    Eliasson L; Renström E; Ammälä C; Berggren PO; Bertorello AM; Bokvist K; Chibalin A; Deeney JT; Flatt PR; Gäbel J; Gromada J; Larsson O; Lindström P; Rhodes CJ; Rorsman P
    Science; 1996 Feb; 271(5250):813-5. PubMed ID: 8628999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulfonylurea-mediated stimulation of insulin exocytosis via an ATP-sensitive K+ channel-independent action.
    Renström E; Barg S; Thévenod F; Rorsman P
    Diabetes; 2002 Feb; 51 Suppl 1():S33-6. PubMed ID: 11815455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells.
    Kramer W; Müller G; Geisen K
    Horm Metab Res; 1996 Sep; 28(9):464-8. PubMed ID: 8911984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Primary and secondary failure of sulphonylureas].
    Kanno H; Sakura H
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():719-23. PubMed ID: 12430308
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of calcium in insulin secretion.
    Malaisse WJ
    Isr J Med Sci; 1972 Mar; 8(3):244-51. PubMed ID: 4557376
    [No Abstract]   [Full Text] [Related]  

  • 34. Dynamics of sulfonylurea-induced insulin release from the isolated perfused rat pancreas.
    Gotfredsen CF
    Diabetologia; 1976 Aug; 12(4):339-42. PubMed ID: 134920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The blood-sugar depressing and betacytotrope effect of glibornurid in healthy and in gastric-resected persons (author's transl)].
    Grabner W; Matzkies F; Randerbrock V; Berg G
    Med Klin; 1973 Aug; 68(34):1101-5. PubMed ID: 4598149
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of the cationic and secretory response of pancreatic islets to gliclazide and/or potassium.
    Mathias PC; Billaudel B; Malaisse WJ
    Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):389-400. PubMed ID: 6320319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological approach to understanding the control of insulin secretion in human islets.
    Henquin JC; Dufrane D; Gmyr V; Kerr-Conte J; Nenquin M
    Diabetes Obes Metab; 2017 Aug; 19(8):1061-1070. PubMed ID: 28116849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of SPC 703, a new sulfonylurea derivative, on the secretion and biosynthesis of insulin by isolated pancreatic islets in the rat].
    Wójcikowski C; Boreysza A; Dominiak K; Arendarczyk W; Gembal M
    Endokrynol Pol; 1987; 38(2):169-78. PubMed ID: 3325281
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man.
    Pfeifer MA; Halter JB; Judzewitsch RG; Beard JC; Best JD; Ward WK; Porte D
    Diabetes Care; 1984; 7 Suppl 1():25-34. PubMed ID: 6376026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [C-peptide secretion dependent on serum glucose and insulin secretion - autoregulation of insulin secretion].
    Zilker T; Ermler R; Paterek K; Bottermann P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1385-8. PubMed ID: 347780
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.